These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29349921)

  • 1. Community pharmacists' views on the regulation of complementary medicines and complementary-medicines practitioners: a qualitative study in New Zealand.
    Barnes J; Butler R
    Int J Pharm Pract; 2018 Dec; 26(6):485-493. PubMed ID: 29349921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacists' professional practices for complementary medicines: a qualitative study in New Zealand.
    Barnes J; Butler R
    Int J Clin Pharm; 2020 Aug; 42(4):1109-1117. PubMed ID: 32686048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.
    Barnes J; Butler R
    Drug Saf; 2020 Nov; 43(11):1157-1170. PubMed ID: 32975740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting pharmacists' recommendation of complementary medicines - a qualitative pilot study of Australian pharmacists.
    Culverhouse SE; Wohlmuth H
    BMC Complement Altern Med; 2012 Oct; 12():183. PubMed ID: 23051066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key stakeholder perspectives on the barriers and solutions to pharmacy practice towards complementary medicines: an Australian experience.
    Ung COL; Harnett J; Hu H
    BMC Complement Altern Med; 2017 Aug; 17(1):394. PubMed ID: 28793918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving pharmacy practice in relation to complementary medicines: a qualitative study evaluating the acceptability and feasibility of a new ethical framework in Australia.
    Popattia AS; Hattingh L; La Caze A
    BMC Med Ethics; 2021 Jan; 22(1):3. PubMed ID: 33407396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expectations and responsibilities regarding the sale of complementary medicines in pharmacies: perspectives of consumers and pharmacy support staff.
    Iyer P; McFarland R; La Caze A
    Int J Pharm Pract; 2017 Aug; 25(4):292-300. PubMed ID: 27633447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of pharmacy practice research - Perspectives of academics and practitioners from Australia, NZ, United Kingdom, Canada and USA.
    Babar ZU; Scahill S; Nagaria RA; Curley LE
    Res Social Adm Pharm; 2018 Dec; 14(12):1163-1171. PubMed ID: 29358030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Funding for change: New Zealand pharmacists' views on, and experiences of, the community pharmacy services agreement.
    Kinsey H; Scahill S; Bye L; Harrison J
    Int J Pharm Pract; 2016 Dec; 24(6):379-389. PubMed ID: 27121985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of non-prescription medicines during lactation: A qualitative study of community pharmacists' attitudes and perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2018 May; 14(5):464-470. PubMed ID: 28624292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' views on and experiences with bowel cancer screening kits in Auckland, New Zealand.
    Martini N; Basdew K; Kammona A; Shen A; Taylor C; McIntosh TR; Barnes J
    Int J Pharm Pract; 2014 Aug; 22(4):257-64. PubMed ID: 24118479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australian community pharmacists' practice in complementary medicines: a structural equation modeling approach.
    Kanjanarach T; Krass I; Cumming RG
    Patient Educ Couns; 2011 Jun; 83(3):352-9. PubMed ID: 21621945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumer-pharmacist interactions around complementary medicines: agreement between pharmacist and consumer expectations, satisfaction and pharmacist influence.
    Tran S; Calabretto JP; Sorich M
    Int J Pharm Pract; 2013 Dec; 21(6):378-85. PubMed ID: 23517229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Do Breastfeeding Women Taking Herbal Galactagogues Perceive of Community Pharmacists' Role in Breastfeeding Support? A Qualitative Study.
    Sim TF; Hattingh HL; Sherriff J; Tee LB
    Int J Environ Res Public Health; 2015 Sep; 12(9):11132-45. PubMed ID: 26371023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative study exploring community pharmacists' awareness of, and contribution to, self-care support in the management of long-term conditions in the United Kingdom.
    Ogunbayo OJ; Schafheutle EI; Cutts C; Noyce PR
    Res Social Adm Pharm; 2015; 11(6):859-79. PubMed ID: 25677228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a strategic model for integrating complementary medicines into professional pharmacy practice.
    Ung COL; Harnett J; Hu H
    Res Social Adm Pharm; 2018 Jul; 14(7):663-672. PubMed ID: 28784591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2013 Dec; 35(6):1218-28. PubMed ID: 24057435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.